CENTRAL MAINE MEDICAL CENTER COMPREHENSIVE CANCER PROGRAM

For more information contact:

Patty Shorthill, Sr. Oncology Research Coordinator
(207) 795-8315
shorthpa@cmhc.org

 

OPEN ONCOLOGY CLINICAL TRIALS

BREAST

E5103: A Double Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer

3144A2 3004: ExteNET: A Randomized Double-Blind Placebo-Controlled Trial of Neratinib (HKI-272) After Trastuzumab in Women With Early-Stage HER-2/neu Overexpressed/Amplified Breast Cancer

NSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

NSABP B-39: A Randomized Phase III Study of Conventional Breast Irradiation (WBI) vs. Partial Breast Irradiation for Women with Stage 0, I, or II Breast Cancer

BRAIN

RTOG 0825: Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma

COLON

CALGB 80702: A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer

HEAD AND NECK

RTOG 0920: A Phase III study of Post Operative Radiation Therapy (IMRT) ± Cetuximab for Locally Advanced Resected Head and Neck Cancer

LUNG

E1505: A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (≥4 cm)-IIIA Non-Small Cell Lung Cancer (NSCLC)

CALGB 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide

H3E-US-S130: Randomized, Open-Label, Phase 3 Study of Pemetrexed plus Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel plus Carboplatin and Bevacizumab Followed by Maintenance Bevacizumab in Patients with Advanced Non-Small Cell Lung Cancer of Nonsquamous Histology

PROSTATE

RTOG 0815: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or Without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

RTOG 0831: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor, Tadalafil, In Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer

PALLIATION

RTOG 0517: Randomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast, and Prostate Cancer

PREVENTON

I-ELCAP (International Early Lung Cancer Action Program): Early Detection of Lung Cancer Using Computed Tomography

 

Web 1/17/2011